Home/DIANA Biotechnologies/Martin Dienstbier
MD

Martin Dienstbier

CFO & COO

DIANA Biotechnologies

DIANA Biotechnologies Pipeline

DrugIndicationPhase
Ultrasensitive Sepsis DiagnosticsSepsisDevelopment/Commercialization
Custom Oligonucleotide Synthesis ServiceResearch/Diagnostic ToolCommercial
Monoclonal Antibody Development ServiceResearch/Therapeutic ToolCommercial
Kinase Inhibitor Profiling ServiceDrug Discovery ResearchCommercial